Third quarter was the best in three years in terms of deals for healthcare, pharma sector.

New Delhi, October 15 (IANS). In the healthcare and pharmaceutical sector, 64 deals worth $2.8 billion were signed in the third quarter (July-September) of 2024, which is the highest deals in three years.

The Grant Thornton India report showed that there has been a significant increase in mergers, acquisitions and private equity (PE) deals with 59 deals worth $2.2 billion, the highest since Q4 2021.

However, the value of deals saw a 47 percent decline in the third quarter of 2024 compared to the second quarter of 2024.

The decline was mainly due to a lack of high-value deals, as only two deals were worth $1.8 billion.

In contrast, Q2 2024 saw 11 high-value deals (worth more than $100 million), totaling $3.4 billion.

Healthtech pharma and biotech and wellness segments collectively powered the number of deals with 66 per cent share. The contribution of pharma and biotech was 79 percent in terms of value.

Bhanu Prakash Kalmath S.J., partner at Grant Thornton India and healthcare industry veteran. “Overall, investor interest in the pharma and healthcare sectors has increased, driven by strong consumer demand focused on healthy living, innovation and high-growth areas such as biologics and specialty care,” it said.

“We expect the pace of deals to continue as companies are positioned for growth domestically and globally,” he said.

The report said there were 26 mergers and acquisitions deals worth $1.9 billion in the third quarter of 2024, bringing the number of deals in the quarter to a record high.

The number of such deals also increased by 44 percent from the second quarter of 2024 and the value of deals increased by 39 percent to $1.9 billion.

Additionally, there were 33 private equity/venture capital deals worth $246 million in Q3 2024. In the absence of big deals, the deal value declined by 91 percent from the second quarter of 2024.

There were also two IPOs worth $459 million in the third quarter of 2024, which is one of the largest IPOs in the sector for 2024. $214 million was raised across three QIPs, representing a significant increase in activity.

–IANS

MKS/AKJ

Comments are closed.